These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26230881)

  • 21. Covalent inactivation of Mycobacterium thermoresistibile inosine-5'-monophosphate dehydrogenase (IMPDH).
    Trapero A; Pacitto A; Chan DS; Abell C; Blundell TL; Ascher DB; Coyne AG
    Bioorg Med Chem Lett; 2020 Jan; 30(2):126792. PubMed ID: 31757668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery.
    Shu Q; Nair V
    Med Res Rev; 2008 Mar; 28(2):219-32. PubMed ID: 17480004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances on the enantioselective synthesis of C-nucleosides inhibitors of inosine monophosphate dehydrogenase (IMPDH).
    Merino P; Ghirardello M; Tejero T; Delso I; Matute R
    Curr Top Med Chem; 2014; 14(10):1212-24. PubMed ID: 24758435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IMPDH as a biological probe for RNA antiviral drug discovery: synthesis, enzymology, molecular docking, and antiviral activity of new ribonucleosides with surrogate bases.
    Nair V; Ma X; Shu Q; Zhang F; Uchil V; Cherukupalli GR
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):651-4. PubMed ID: 18066873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In silico design of human IMPDH inhibitors using pharmacophore mapping and molecular docking approaches.
    Li RJ; Wang YL; Wang QH; Wang J; Cheng MS
    Comput Math Methods Med; 2015; 2015():418767. PubMed ID: 25784957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and In Vitro Enzymatic Studies of New 3-Aryldiazenyl Indoles as Promising Helicobacter pylori IMPDH Inhibitors.
    Jangra S; Purushothaman G; Juvale K; Ravi S; Menon A; Thiruvenkatam V; Kirubakaran S
    Curr Top Med Chem; 2019; 19(5):376-382. PubMed ID: 30827248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The structural basis of Cryptosporidium -specific IMP dehydrogenase inhibitor selectivity.
    Macpherson IS; Kirubakaran S; Gorla SK; Riera TV; D'Aquino JA; Zhang M; Cuny GD; Hedstrom L
    J Am Chem Soc; 2010 Feb; 132(4):1230-1. PubMed ID: 20052976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IMP dehydrogenase: the dynamics of drug selectivity.
    Hedstrom L; Gan L; Schlippe YG; Riera T; Seyedsayamdost M
    Nucleic Acids Res Suppl; 2003; (3):97-8. PubMed ID: 14510398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico 3-D structure prediction and molecular docking studies of inosine monophosphate dehydrogenase from Plasmodium falciparum.
    Raza M; Khan Z; Ahmad A; Raza S; Khan A; Mohammadzai IU; Zada S
    Comput Biol Chem; 2017 Dec; 71():10-19. PubMed ID: 28957725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repurposing existing drugs: identification of irreversible IMPDH inhibitors by high-throughput screening.
    Sarwono AEY; Mitsuhashi S; Kabir MHB; Shigetomi K; Okada T; Ohsaka F; Otsuguro S; Maenaka K; Igarashi M; Kato K; Ubukata M
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):171-178. PubMed ID: 30451014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitors of inosine monophosphate dehydrogenase: probes for antiviral drug discovery.
    Story S; Gupta M; Bonsu E; Nair V
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):717-20. PubMed ID: 16248022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, and biological evaluation of Helicobacter pylori inosine 5'-monophosphate dehydrogenase (HpIMPDH) inhibitors.
    Sahu NU; Purushothaman G; Thiruvenkatam V; Kharkar PS
    Drug Dev Res; 2019 Feb; 80(1):125-132. PubMed ID: 30381846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expanding Benzoxazole-Based Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor Structure-Activity As Potential Antituberculosis Agents.
    Chacko S; Boshoff HIM; Singh V; Ferraris DM; Gollapalli DR; Zhang M; Lawson AP; Pepi MJ; Joachimiak A; Rizzi M; Mizrahi V; Cuny GD; Hedstrom L
    J Med Chem; 2018 Jun; 61(11):4739-4756. PubMed ID: 29746130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis and biological evaluation of Helicobacter pylori inosine 5'-monophosphate dehydrogenase (HpIMPDH) inhibitors. Further optimization of selectivity towards HpIMPDH over human IMPDH2.
    Shah CP; Purushothaman G; Thiruvenkatam V; Kirubakaran S; Juvale K; Kharkar PS
    Bioorg Chem; 2019 Jun; 87():753-764. PubMed ID: 30974298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycobacterium tuberculosis IMPDH in Complexes with Substrates, Products and Antitubercular Compounds.
    Makowska-Grzyska M; Kim Y; Gorla SK; Wei Y; Mandapati K; Zhang M; Maltseva N; Modi G; Boshoff HI; Gu M; Aldrich C; Cuny GD; Hedstrom L; Joachimiak A
    PLoS One; 2015; 10(10):e0138976. PubMed ID: 26440283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational insights into the inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid analogs: three-dimensional quantitative structure-activity relationship and molecular docking studies.
    Yang N; Wang J; Wang ZW; Wang QH; Yang HG; Wang XJ; Cheng MS
    Chem Biol Drug Des; 2012 Jun; 79(6):1063-71. PubMed ID: 22405057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part II. In vitro studies.
    Wright DG; Boosalis M; Malek K; Waraska K
    Leuk Res; 2004 Nov; 28(11):1137-43. PubMed ID: 15380336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virtual and experimental high-throughput screening (HTS) in search of novel inosine 5'-monophosphate dehydrogenase II (IMPDH II) inhibitors.
    Dunkern T; Prabhu A; Kharkar PS; Goebel H; Rolser E; Burckhard-Boer W; Arumugam P; Makhija MT
    J Comput Aided Mol Des; 2012 Nov; 26(11):1277-92. PubMed ID: 23117549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cofactor-type inhibitors of inosine monophosphate dehydrogenase via modular approach: targeting the pyrophosphate binding sub-domain.
    Felczak K; Chen L; Wilson D; Williams J; Vince R; Petrelli R; Jayaram HN; Kusumanchi P; Kumar M; Pankiewicz KW
    Bioorg Med Chem; 2011 Mar; 19(5):1594-605. PubMed ID: 21324702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics and crystal structure of bacterial inosine-5'-monophosphate dehydrogenase.
    Zhang R; Evans G; Rotella FJ; Westbrook EM; Beno D; Huberman E; Joachimiak A; Collart FR
    Biochemistry; 1999 Apr; 38(15):4691-700. PubMed ID: 10200156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.